期刊文献+

胃肠道肿瘤术后腹壁转移患者的介入治疗 被引量:1

Interventional therapy for abdominal wall metastasis of gastroenterological carcinoma
下载PDF
导出
摘要 目的探讨胃肠道肿瘤术后腹壁转移灶采用介入治疗的疗效和并发症。方法对5例胃肠道肿瘤术后腹壁转移灶患者采用化疗栓塞术,部分患者结合经皮穿刺瘤内注射无水乙醇。结果 5例患者行动脉插管化疗栓塞术获得技术成功,术后3例患者腹壁转移灶内碘油沉积良好。5例患者症状均缓解,癌胚抗原(CEA)有不同程度下降,未发生严重并发症。手术成功率100%,随访半年以上未发现肿瘤复发。结论胃肠道肿瘤术后腹壁转移灶采取介入方法治疗可使肿瘤病灶缩小,可有效控制肿瘤生长、缓解疼痛,提高患者生存质量。 Objective To explore the efficacy and complication of interventional therapy for abdominal wall metastasis of gastroenterological carcinoma. Methods 5 patients with abdominal wall metastasis after gastrointestinal cancer operation were treated with transcatheter arterial chemoembolization, some patients were treated with percutaneous intratumor ethanol injection(PEI). ResultsInterventional treatment was suceessfully performed in 5 patients with good lipiodol deposition within the lesions in 3 cases,partial depositions in 2 cases and followed by PEI. Pain caused by abdominal wall metastasis was alleviated or eliminated with tumor shrinkage and softened in 5 patients. CEA levels decreased in all 5 patients after therapy. No other severe complication occurred. Technical success was achieved in 5 sessions(100%). Six-month follow-up was available for 5 tumors, no imaging evidence of local tumor progression. Conclusion Transcatheter arterial embolization and PEI for patients with abdominal wall metastasis of gastroenterological carcinoma could narrow tumor lesions, control the development and relieve pain effectively, it could improve the patients living quality.
作者 郑宝权 姜野
出处 《医疗装备》 2016年第5期159-160,共2页 Medical Equipment
关键词 胃肠道肿瘤 腹壁转移 介入栓塞 经皮穿刺瘤内注射无水乙醇 gastroenterological carcinoma abdominal wall metastasis interventional therapy percutaneous intratumor ethanol injection
  • 相关文献

参考文献5

二级参考文献27

  • 1高峻,韩殿冰,张朝.胆囊癌临床研究进展[J].河南外科学杂志,2010,16(2):88-89. 被引量:15
  • 2刘辉,李晓莉,朱勤,胡煜,宴鹰,张阳德.123例原发性胆囊癌的临床诊治评析[J].中国医学工程,2005,13(6):637-639. 被引量:2
  • 3姚红响,陈根生,刘伟,陈洪波,张卫平,曾群.原发性肝癌腹壁转移的介入治疗[J].介入放射学杂志,2006,15(12):722-724. 被引量:2
  • 4徐新保,张辉,张宏义,张洪义.腹腔镜胆囊切除术后胆囊癌腹腔广泛转移及脐部戳卡孔种植一例[J].空军总医院学报,2007,23(1):55-56. 被引量:2
  • 5Li YH, Wang CS, Liao LY, et al. Long-term survival of Taiwan Residents patients with hepatocellular carcinoma after combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection. J Formos Med Assoc, 2003,102:141-146.
  • 6Allgaier HP, Deibert P, Olschewski M, et al. Survival benefit of patients with inoperable hepatocellular carcinoma treated by a combination of transarterial chemoembolization and percutaneous ethanol injection-a single-center alalysis including 132 patients. Int J Cancer, 1998,79:601-615.
  • 7Koda M, Murawaki Y, Mitsuda A, et al. Combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection compared with percutaneous ethanol injection alone for patients with small pepatocellular carcinoma:a randomized control study. Cancer,2001,92:1516-1524.
  • 8Kamada K, Kitamoto M, Aikata H, et al. Combination of transcatheter arterial chemoembolization using cisplatin-lipiodol suspension and percutaneous ethanol injection for treatment of advanced small hepatocellular carcinoma. Am J Surg, 2002,184:284-290.
  • 9Arata S, Tanaka K, Okazaki H, et al. Risk factors for recurrence of large HCC in patients treated by combined TAE and PEI. Hepato-gastroenterology, 2001,48:480-485.
  • 10Livraghi T, Guidelines for treatment of liver cancer. Ultrasound, 2001,13:167-176.

共引文献17

同被引文献7

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部